Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia
- 15 October 2012
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 160 (2) , 220-227
Abstract
Summary: Heritable dysfibrinogenaemia (HD) is a rare qualitative disorder of fibrinogen (FGN). To better describe the clinical, laboratory and genotypic spectrum of HD, we evaluated 35 subjects identified at two UK centres using laboratory criteria. 12/35(34%) subjects with HD experienced bleeding (bleeding score >1 at any site), 3/35(9%) thrombosis and 20/35(57%) were asymptomatic. Amongst subjects with bleeding, symptoms were typically mild, at one anatomical site and seldom occurred after invasive procedures. All subject showed dry clot weight within or above laboratory reference interval (median 3·2 g/l; range 1·9–5·1), reduced Clauss fibrinogen (median 0·52 g/l; range 0·21–1·3), and prolonged thrombin (median 30·7 s; range 21·3–45·7) and reptilase (median 42·0 s; range 20·0–68·0) times. In all subjects, the prothrombin time ratio (PTR), determined by Sysmex CA‐1500 coagulometer and Innovin activator, was abnormal (median 1·42; range 1·22–1·61). The activated partial thromboplastin time ratio and PTR with other coagulometers and activators were comparatively insensitive to HD. All subjects with HD harboured heterozygous candidate nucleotide variations within known hotspots in the FGN genes. The HD variants identified in this cross‐sectional study seldom have significant clinical manifestations and show similar laboratory features irrespective of genotype. Selection of coagulometer and PT activator may markedly affect the detection of new HD cases using coagulation screening tests.Keywords
This publication has 29 references indexed in Scilit:
- Molecular Mechanisms Affecting Fibrin Structure and StabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis, 2010
- Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defectsBlood Coagulation & Fibrinolysis, 2010
- High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertensionBlood, 2009
- Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemiasHaemophilia, 2008
- Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations(γAla341Thr, Bβ Tyr326Cys and Aα Asp496Asn)Thrombosis and Haemostasis, 2007
- A classification of the fibrin network structures formed from the hereditary dysfibrinogensJournal of Thrombosis and Haemostasis, 2006
- The dysfibrinogenaemiasBritish Journal of Haematology, 2001
- Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemiasBlood Coagulation & Fibrinolysis, 1995
- The Sequence of Cleavage of Fibrinopeptides from Fibrinogen is Important for Protofibril Formation and Enhancement of Lateral Aggregation in Fibrin ClotsJournal of Molecular Biology, 1993